The 7 analysts offering 1 year price forecasts for PCR have a max estimate of — and a min estimate of —.
Analyst rating
Based on 9 analysts giving stock ratings to PCR in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
PCR EPS for the last quarter is 0.56 EUR despite the estimation of 0.76 EUR. In the next quarter EPS is expected to reach 0.89 EUR. Track more of POWER CORP OF CANADA financials and stay on top of what is up with the company.
In the next quarter POWER CORP OF CANADA revenue is expected to reach 2.66 B EUR. Check out POWER CORP OF CANADA revenue and earnings and make informed decisions.
According to analysts, PCR price target is 34.30 EUR with a max estimate of 37.87 EUR and a min estimate of 33.14 EUR. Check if this forecast comes true in a year, meanwhile watch POWER CORP OF CANADA stock price chart and keep track of the current situation with PCR news and stock market news.
We've gathered opinions of 9 analysts rating PCR stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.